|
New pieces in the autism inheritance puzzle (News-Medical-Net)
Pieces in the complex autism inheritance puzzle are emerging in the latest study from a research team including geneticists from the University of Pennsylvania School of Medicine and The Children's Hospital of Philadelphia (CHOP). The study identified 27 different genetic regions where rare copy number variations - missing or extra copies of DNA segments - were found in the genes of children ...
(Jun 30, 2009)
New test detects genetic and chromosomal abnormalities in embryos - ready for clinical trials (News-Medical-Net)
One-step screening for both genetic and chromosomal abnormalities has come a stage closer as scientists announced that an embryo test they have been developing has successfully screened cells taken from spare embryos that were known to have cystic fibrosis.
(Jun 30, 2009)
Growing Proteomics Market and the Current Economic Crisis Could Act in Tandem to Spur Growth in the European 2 ... (redOrbit)
LONDON, June 30 /PRNewswire/ -- Two-dimensional electrophoresis (2DE) is the most cost-effective protein profiling technology and is the only technology in which the constituents of a protein sample can be entirely visualised in a single gel.
(Jun 30, 2009)
Senator Kohl: Marshfield Clinic set the standard for quality health care (Marshfield News Herald)
Sen. Herb Kohl said Monday that the Marshfield Clinics level of patient care, costs and constant push to move medicine forward, make it an example for a nation, and government, debating major health care reform.
(Jun 30, 2009)
Hunt for Blood Test to Determine Melanoma Survival Rates (PhysOrg)
(PhysOrg.com) -- Research at the University of Leicester will be breaking new ground in the search for a simple blood test that could tell whether a patient with melanoma has the condition in an aggressive form.
(Jun 30, 2009)
New test can detect both genetic and chromosomal abnormalities in embryos (EurekAlert!)
( European Society for Human Reproduction and Embryology ) One-step screening for both genetic and chromosomal abnormalities has come a stage closer as scientists announced that an embryo test they have been developing has successfully screened cells taken from spare embryos that were known to have cystic fibrosis
(Jun 30, 2009)
Hunt For The Blood Test To Determine Melanoma Survival Rates (Science Daily)
New research will be breaking new ground in the search for a simple blood test that could tell whether a patient with melanoma has the condition in an aggressive form. Melanoma is the most aggressive form of skin cancer. Staging, which involves determining the size of the tumor and its extent of spread, is the best predictor of whether a patient will succumb to disease or survive.
(Jun 30, 2009)
Over 25 New Features in Geneious(TM) 4.7 (Marketwire)
AUCKLAND, NEW ZEALAND--(Marketwire - June 30, 2009) - GeneiousT 4.7 boasts a new ultra-fast sequence assembler that allows users to assemble sequences generated from the Sanger and 454 high-throughput methods to a reference genome. GeneiousT version 4.7 is the first release in a three-phase release-strategy that will provide increasing support for next-generation high-throughput sequence data ...
(Jun 30, 2009)
New Take On Growth Factor Signaling In Tamoxifen Resistance (Science Daily)
Differences in growth factor (GF) signaling may cause the poor prognosis in some breast cancer cases. A new study suggests that some estrogen receptor-positive breast cancers respond poorly to tamoxifen because of increased GF signaling.
(Jun 30, 2009)
Rubicon Genomics Introduces PicoPlex Single Cell Whole Genome Amplification Kit for Pre-Implantation Genetic ... (Business Wire via Yahoo! Finance)
ANN ARBOR, Mich.----Rubicon Genomics, Inc., a developer of pre-amplification products that enable optimal performance of the most advanced genetic analysis tools, announced today the release of its PicoPlex™ Single Cell Whole Genome Amplification kit--a more rapid, accurate and reproducible method for amplifying single genomes than current technologies.
(Jun 30, 2009)
Q&A: Belgian Cyto Lab to Evaluate OGT's Arrays for Prenatal Diagnostics Service (GenomeWeb News)
Background: Vermeesch heads the constitutional cytogenetics unit of the Center of Human Genetics in Katholieke Universiteit Leuven. Previously he was head of the genomics unit in the basic research division of Aventis CropScience. He holds a PhD in biochemistry from the University of Nebraska.
(Jun 30, 2009)
New Biomarker Method Could Increase The Number Of Diagnostic Tests For Cancer (Medical News Today)
A team of researchers has demonstrated that a new method for detecting and quantifying protein biomarkers in body fluids may ultimately make it possible to screen multiple biomarkers in hundreds of patient samples, thus ensuring that only the strongest biomarker candidates will advance down the development pipeline.
(Jun 30, 2009)
This Week in PNAS (GenomeWeb News)
In PNAS this week, Steven Gygi at Harvard led work that used stable-isotope dilution and high-resolution mass spec to measure kinase activity. His multiplexed assay was able to measure up to 90 site-specific peptide phosphorylation rates at the same time, and he could apply it to a variety of cells and cellular processes, including mitogen stimulation, cell cycle, pharmacological inhibition of ...
(Jun 30, 2009)
Test Can Detect Both Genetic And Chromosomal Abnormalities In Embryos (redOrbit)
One-step screening for both genetic and chromosomal abnormalities has come a stage closer as scientists announced that an embryo test they have been developing has successfully screened cells taken from spare embryos that were known to have cystic fibrosis.They told a news briefing at the 25th annual meeting of the European Society of Human Reproduction and Embryology in Amsterdam today ...
(Jun 30, 2009)
Bayer Deal Not Enough for Celera (Zacks.com via Yahoo! Finance)
Bayer Deal Not Enough for Celera
(Jun 30, 2009)
New Products (GenomeWeb News)
Biomatters has released Geneious 4.7 beta , a new version of its bioinformatics sequence analysis platform. Version 4.7 includes a new DNA sequence assembler that allows users to align sequences generated on the Sanger and 454 platforms to a reference genome.
(Jun 30, 2009)
Paired Ends (GenomeWeb News)
French immunologist Jean Dausset died earlier this month at the age of 92. In 1958, he discovered the human leukocyte antigen, HLA, and shared the Nobel Prize for medicine in 1980 with George Snell and Baruj Benacerraf . In 1984, Dausset founded the Centre d'Etude du Polymorphisme Humain , today called the Foundation Jean Dausset-CEPH , which helped create a genetic and physical map of the human ...
(Jun 30, 2009)
Invitrogen Positions New Array System for HLA-Testing Market (GenomeWeb News)
Invitrogen this week expanded its microarray portfolio with the debut of its Prodigy system, an automated instrument designed to help develop immunogenetic tests, such as human leukocyte antigen typing.
(Jun 30, 2009)
Q&A: BC Cancer Agency's Robert Holt on Sequencing the Immune Repertoire (GenomeWeb News)
Rob Holt has been heading sequencing at the British Columbia Cancer Agency's Genome Sciences Centre since 2002, after spending four years at Celera Genomics.
(Jun 30, 2009)
Gentel Biosciences Launches APiX Chromogenic Protein Array System (Business Wire via Yahoo! Finance)
MADISON, Wis.----Gentel Biosciences, Inc., a leading protein microarray technologies firm, announced today the availability of its APiX™ Chromogenic Protein Array System to the global research community.
(Jun 30, 2009)
Enabled by New Sequencing Techs, JGI Projects 300 GB of Data for 2010 Community Sequencing Program (GenomeWeb News)
New sequencing technologies will play an important role in 71 new genomic sequencing projects that the Department of Energy's Joint Genome Institute announced yesterday for its 2010 Community Sequencing Program.
(Jun 30, 2009)
Horse Racing Enters Proteomics Age: UK Firm Developing Technology to Detect Steroid Use in Ponies (GenomeWeb News)
It isn't only baseball players and track stars who dope up to gain an upper hand on the playing field. Horse trainers and owners do also.
(Jun 30, 2009)
Aushon Technology Chosen for Small Molecule Microarray Research (Business Wire via Yahoo! Finance)
BILLERICA, Mass.----Aushon BioSystems, Inc., a leading provider of advanced microarray instrumentation and laboratory services for biomarker discovery, development and analysis recently announced that the Eli and Edythe L.
(Jun 30, 2009)
Castle Biosciences to work with St. Joseph’s Hospital on brain cancer test (BizJournals)
Castle Biosciences Inc. has joined with St. Joseph’s Hospital and Medical Center in Phoenix to provide the nation’s first genomics-based test for patients suffering from glioblastoma multiforme — the most deadly form of primary brain cancer.
(Jun 30, 2009)
ViraCor, IBT to Merge (GenomeWeb News)
NEW YORK (GenomeWeb News) – ViraCor Laboratories and IBT Laboratories announced today that they will merge to form a new specialty diagnostic testing lab.
(Jun 30, 2009)
Researchers using microRNA to identify aggressive melanoma (News-Medical-Net)
Research at the University of Leicester will be breaking new ground in the search for a simple blood test that could tell whether a patient with melanoma has the condition in an aggressive form.
(Jun 30, 2009)
Myriad Genetics' Q4, FY 2009 Revenues to Come Up Short (GenomeWeb News)
NEW YORK (GenomeWeb News) – Myriad Genetics said after the close of the market Tuesday that it expects its fourth-quarter and full-year 2009 molecular diagnostic revenues to be lower than previously expected.
(Jun 30, 2009)
Who Will Helm Kaiser's Molecular Genetics Lab? Permanente Search Enters Fifth Week (GenomeWeb News)
Kaiser Permanente has been looking to hire a director for its molecular genetics laboratory in San Jose, Calif. The search, which is being conducted through at least four online job-recruitment web sites, has been going on for at least five weeks.
(Jun 30, 2009)
SEC Investigating Sequenom over Down Syndrome Test (GenomeWeb News)
NEW YORK (GenomeWeb News) – Sequenom disclosed in a filing with the US Securities and Exchange Commission today that the SEC is investigating the firm over its announcement in late April regarding the mishandling of R&D test data and results for its SEQureDx Down syndrome test.
(Jun 30, 2009)
Genetic analysis reveals secrets of scorpion venom (EurekAlert!)
Transcriptomic tests have uncovered the protein composition of venom from the Scorpiops jendeki scorpion. Researchers writing in the open access journal BMC Genomics have carried out the first ever venom analysis in this arachnid, and discovered nine novel poison molecules never before seen in any scorpion species.
(Jun 30, 2009)
|
